Clinical Trial: Drug-drug Interaction Study Between UIC202304, and UIC202305

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07735052) titled 'Drug-drug Interaction Study Between UIC202304, and UIC202305' on July 21.

Brief Summary: A randomized, open-label, two-sequence, two-period, multiple-dose, study to evaluate pharmacokinetic drug-drug interaction, safety and tolerability of UIC202304 and UIC202305 in healthy volunteers.

Study Start Date: Sept. 25, 2023

Study Type: INTERVENTIONAL

Condition: Healhty

Intervention: DRUG: UIC202304 and co-administration of UIC202304 and UIC202305

* UIC202304 1 Tab/day for 9 days

* UIC202304 1 Tab/day + UIC202305 1 Tab/day for 7 days

DRUG: UIC202305 and co-administration of UIC202304 and UIC202305

* UIC202305 1 Tab/day for 7 days...